Lutonix Global SFA Registry
A Prospective, Global Multicenter, Single Arm Real-World Registry Investigating the Clinical Use and Safety of the LUTONIX Drug Coated PTA Dilatation Catheter
Sponsor: Bard Ltd
This observational or N/A phase trial investigates Peripheral Artery Disease and is currently completed. Bard Ltd leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bard Ltd
- C. R. Bard
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aarau, Switzerland, Antwerp, Belgium, Arnsberg, Germany, Asti, Italy, Barcelona, Spain, Bydgoszcz, Poland, Dijon, France, Liverpool, United Kingdom, London, United Kingdom, Manchester, United Kingdom and 12 more location s